Opti Capital Management, LP Quant / Systematic

Location: New York, NY

CIK: 0001738654 · Show all filings

Period: Q1 2021 (← Previous) (Next →)

Filing Date: May 17, 2021

Total Value: $819M (0.2% shares, 99.8% debt)

Holdings (35)

— NUANCE COMMUNICATIONS INC 12.3%

Value $101M Shares 54,544,000 Est. Cost $1.72 Unrealized —

— TERADYNE INC 10.9%

Value $89.3M Shares 23,202,000 Est. Cost $4.52 Unrealized —

— NEW RELIC INC 7.6%

Value $62.2M Shares 63,328,000 Est. Cost $1.17 Unrealized —

— AVAYA HLDGS CORP 5.5%

Value $45.36M Shares 36,500,000 Est. Cost $1.05 Unrealized —

— AKAMAI TECHNOLOGIES INC 5.4%

Value $44M Shares 36,240,000 Est. Cost $1.21 Unrealized —

— REALPAGE INC 5.1%

Value $41.73M Shares 20,000,000 Est. Cost $2.09 Unrealized —

— SNAP INC 5.0%

Value $41.33M Shares 17,500,000 Est. Cost $2.36 Unrealized —

— II-VI INC 4.6%

Value $38.01M Shares 24,900,000 Est. Cost $1.53 Unrealized —

— SUPERNUS PHARMACEUTICALS INC 4.4%

Value $36.34M Shares 37,347,000 Est. Cost $1.77 Unrealized —

— FIREEYE INC 4.2%

Value $34.7M Shares 34,833,000 Est. Cost $2.09 Unrealized —

— EXACT SCIENCES CORP 4.0%

Value $32.86M Shares 17,483,000 Est. Cost $1.89 Unrealized —

— RETROPHIN INC 3.4%

Value $28.02M Shares 27,582,000 Est. Cost $1.21 Unrealized —

— LIBERTY MEDIA CORP DEL 2.8%

Value $22.63M Shares 21,808,156 Est. Cost $1.04 Unrealized —

— LUMENTUM HLDGS INC 2.6%

Value $20.91M Shares 13,000,000 Est. Cost $1.65 Unrealized —

— RAMBUS INC DEL 2.0%

Value $16.18M Shares 13,500,000 Est. Cost $1.57 Unrealized —

— OMEROS CORP 1.9%

Value $15.87M Shares 13,200,000 Est. Cost $1.71 Unrealized —

— VONAGE HLDGS CORP 1.9%

Value $15.81M Shares 15,070,000 Est. Cost $1.06 Unrealized —

— CYTOKINETICS INC 1.9%

Value $15.49M Shares 6,500,000 Est. Cost $4.95 Unrealized —

— IONIS PHARMACEUTICALS INC 1.7%

Value $13.87M Shares 14,500,000 Est. Cost $1.02 Unrealized —

— PLURALSIGHT INC 1.6%

Value $13.31M Shares 13,500,000 Est. Cost $0.99 Unrealized —

— INFINERA CORP 1.4%

Value $11.12M Shares 7,600,000 Est. Cost $1.46 Unrealized —

— FLEXION THERAPEUTICS INC 1.3%

Value $10.99M Shares 12,158,000 Est. Cost $0.90 Unrealized —

— PTC THERAPEUTICS INC 1.2%

Value $9.796M Shares 8,500,000 Est. Cost $2.51 Unrealized —

— KARYOPHARM THERAPEUTICS INC 1.1%

Value $9.367M Shares 9,000,000 Est. Cost $1.04 Unrealized —

— OPKO HEALTH INC 1.0%

Value $8.296M Shares 6,200,000 Est. Cost $2.12 Unrealized —

— ALTERYX INC 1.0%

Value $8.027M Shares 8,500,000 Est. Cost $0.94 Unrealized —

— APELLIS PHARMACEUTICALS INC 0.9%

Value $7.043M Shares 5,000,000 Est. Cost $1.68 Unrealized —

— 8X8 INC NEW 0.9%

Value $6.966M Shares 5,000,000 Est. Cost $1.63 Unrealized —

— IRONWOOD PHARMACEUTICALS INC 0.7%

Value $5.87M Shares 5,300,000 Est. Cost $0.99 Unrealized —

— EVOLENT HEALTH INC 0.6%

Value $4.765M Shares 5,000,000 Est. Cost $0.95 Unrealized —

— NUTANIX INC 0.4%

Value $3.684M Shares 3,761,000 Est. Cost $1.99 Unrealized —

— OMEROS CORP 0.3%

Value $2.498M Shares 2,000,000 Est. Cost $1.25 Unrealized —

— INFINERA CORP 0.1%

Value $1.006M Shares 104,517 Est. Cost $9.63 Unrealized —

T AT&T INC 0.1%

Value $539K Shares 17,800 Est. Cost $15.38 Unrealized +5.0%

ITRI ITRON INC 0.0%

Value $355K Shares 4,000 Est. Cost $98.89 Unrealized 0.0%

Ticker	Issuer	Shares	Value	%	Est. Cost	Unrealized	Class	CUSIP
—	NUANCE COMMUNICATIONS INC	54,544,000	$101M	12.3%	$1.72	—	DBCV 1.000%12/1	67020YAK6
—	TERADYNE INC	23,202,000	$89.3M	10.9%	$4.52	—	NOTE 1.250%12/1	880770AG7
—	NEW RELIC INC	63,328,000	$62.2M	7.6%	$1.17	—	NOTE 0.500% 5/0	64829BAB6
—	AVAYA HLDGS CORP	36,500,000	$45.36M	5.5%	$1.05	—	NOTE 2.250% 6/1	05351XAB7
—	AKAMAI TECHNOLOGIES INC	36,240,000	$44M	5.4%	$1.21	—	NOTE 0.125% 5/0	00971TAJ0
—	REALPAGE INC	20,000,000	$41.73M	5.1%	$2.09	—	NOTE 1.500%11/1	75606NAB5
—	SNAP INC	17,500,000	$41.33M	5.0%	$2.36	—	NOTE 0.750% 8/0	83304AAB2
—	II-VI INC	24,900,000	$38.01M	4.6%	$1.53	—	NOTE 0.250% 9/0	902104AB4
—	SUPERNUS PHARMACEUTICALS INC	37,347,000	$36.34M	4.4%	$1.77	—	NOTE 0.625% 4/0	868459AD0
—	FIREEYE INC	34,833,000	$34.7M	4.2%	$2.09	—	NOTE 1.625% 6/0	31816QAD3
—	EXACT SCIENCES CORP	17,483,000	$32.86M	4.0%	$1.89	—	NOTE 1.000% 1/1	30063PAA3
—	RETROPHIN INC	27,582,000	$28.02M	3.4%	$1.21	—	NOTE 2.500% 9/1	761299AB2
—	LIBERTY MEDIA CORP DEL	21,808,156	$22.63M	2.8%	$1.04	—	DEB 2.250% 9/3	531229AE2
—	LUMENTUM HLDGS INC	13,000,000	$20.91M	2.6%	$1.65	—	NOTE 0.250% 3/1	55024UAB5
—	RAMBUS INC DEL	13,500,000	$16.18M	2.0%	$1.57	—	NOTE 1.375% 2/0	750917AG1
—	OMEROS CORP	13,200,000	$15.87M	1.9%	$1.71	—	NOTE 6.250%11/1	682143AE2
—	VONAGE HLDGS CORP	15,070,000	$15.81M	1.9%	$1.06	—	NOTE 1.750% 6/0	92886TAJ1
—	CYTOKINETICS INC	6,500,000	$15.49M	1.9%	$4.95	—	NOTE 4.000%11/1	23282WAA8
—	IONIS PHARMACEUTICALS INC	14,500,000	$13.87M	1.7%	$1.02	—	NOTE 0.125%12/1	462222AB6
—	PLURALSIGHT INC	13,500,000	$13.31M	1.6%	$0.99	—	NOTE 0.375% 3/0	72941BAB2
—	INFINERA CORP	7,600,000	$11.12M	1.4%	$1.46	—	NOTE 2.500% 3/0	45667GAE3
—	FLEXION THERAPEUTICS INC	12,158,000	$10.99M	1.3%	$0.90	—	NOTE 3.375% 5/0	33938JAB2
—	PTC THERAPEUTICS INC	8,500,000	$9.796M	1.2%	$2.51	—	NOTE 3.000% 8/1	69366JAB7
—	KARYOPHARM THERAPEUTICS INC	9,000,000	$9.367M	1.1%	$1.04	—	NOTE 3.000%10/1	48576UAA4
—	OPKO HEALTH INC	6,200,000	$8.296M	1.0%	$2.12	—	NOTE 4.500% 2/1	68375NAD5
—	ALTERYX INC	8,500,000	$8.027M	1.0%	$0.94	—	NOTE 0.500% 8/0	02156BAD5
—	APELLIS PHARMACEUTICALS INC	5,000,000	$7.043M	0.9%	$1.68	—	NOTE 3.500% 9/1	03753UAB2
—	8X8 INC NEW	5,000,000	$6.966M	0.9%	$1.63	—	NOTE 0.500% 2/0	282914AB6
—	IRONWOOD PHARMACEUTICALS INC	5,300,000	$5.87M	0.7%	$0.99	—	NOTE 0.750% 6/1	46333XAF5
—	EVOLENT HEALTH INC	5,000,000	$4.765M	0.6%	$0.95	—	NOTE 1.500%10/1	30050BAD3
—	NUTANIX INC	3,761,000	$3.684M	0.4%	$1.99	—	NOTE 1/1	67059NAB4
—	OMEROS CORP	2,000,000	$2.498M	0.3%	$1.25	—	NOTE 5.250% 2/1	682143AG7
—	INFINERA CORP	104,517	$1.006M	0.1%	$9.63	—	COM	45667G103
T	AT&T INC	17,800	$539K	0.1%	$15.38	+5.0%	COM	00206R102
ITRI	ITRON INC	4,000	$355K	0.0%	$98.89	0.0%	COM	465741106